PAGANELLI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 1.956
EU - Europa 918
AS - Asia 316
SA - Sud America 24
OC - Oceania 19
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.249
Nazione #
US - Stati Uniti d'America 1.920
IT - Italia 309
FR - Francia 171
CN - Cina 136
SE - Svezia 126
DE - Germania 81
VN - Vietnam 46
PL - Polonia 38
GB - Regno Unito 37
CA - Canada 34
IN - India 34
RU - Federazione Russa 27
JP - Giappone 20
FI - Finlandia 15
BE - Belgio 14
CZ - Repubblica Ceca 14
ES - Italia 13
IE - Irlanda 13
NL - Olanda 13
AE - Emirati Arabi Uniti 11
AU - Australia 11
HK - Hong Kong 11
BR - Brasile 10
ID - Indonesia 9
UA - Ucraina 9
CL - Cile 8
NZ - Nuova Zelanda 8
ZA - Sudafrica 8
IR - Iran 7
PT - Portogallo 7
SG - Singapore 7
DK - Danimarca 6
JO - Giordania 6
KR - Corea 6
TR - Turchia 6
CH - Svizzera 5
CO - Colombia 4
LT - Lituania 4
SA - Arabia Saudita 4
AP - ???statistics.table.value.countryCode.AP??? 3
BA - Bosnia-Erzegovina 3
GR - Grecia 3
TW - Taiwan 3
AT - Austria 2
BO - Bolivia 2
IQ - Iraq 2
JM - Giamaica 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SC - Seychelles 2
SI - Slovenia 2
CY - Cipro 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
MA - Marocco 1
MN - Mongolia 1
MY - Malesia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
Totale 3.249
Città #
Santa Cruz 225
Fairfield 172
Ashburn 152
Houston 138
Stockholm 124
Woodbridge 98
Seattle 90
Cambridge 71
Buffalo 70
Bologna 66
Ann Arbor 63
Des Moines 57
Wilmington 47
Ferrara 46
Dong Ket 44
San Diego 36
Warsaw 32
Chicago 31
Boardman 25
Los Angeles 20
Bengaluru 17
Las Vegas 16
New York 16
Paris 16
Beijing 15
Guangzhou 14
Dublin 12
Ferrara di Monte Baldo 11
Helsinki 11
Milan 11
Phoenix 11
Rome 11
San Francisco 11
Shanghai 11
Hangzhou 10
Santa Giustina 10
Shenyang 10
Ottawa 9
Toronto 9
Albuquerque 7
Changsha 7
Jacksonville 7
Saint Petersburg 7
San Jose 7
Vicenza 7
Auckland 6
Cedar Knolls 6
Fleming Island 6
Hanover 6
Henderson 6
London 6
Modena 6
Muizenberg 6
Scranton 6
Tokyo 6
Wuhan 6
Boves 5
Clearwater 5
Council Bluffs 5
Heidelberg 5
Lucknow 5
Madrid 5
Mol 5
Portland 5
Québec 5
Absecon 4
Amsterdam 4
Ancona 4
Boulder 4
Chengdu 4
Dallas 4
Dundee 4
Lake Forest 4
Lappeenranta 4
Nakskov 4
Naples 4
Poznan 4
Provo 4
Rimini 4
Riva 4
Rotterdam 4
Salamanca 4
Tappahannock 4
Trento 4
Atlanta 3
Auburn 3
Bogotá 3
Brooklyn 3
Campina Grande 3
Central 3
Central District 3
Changchun 3
Columbus 3
Duncan 3
Esslingen am Neckar 3
Florence 3
Genova 3
Ghent 3
Glasgow 3
Grenoble 3
Totale 2.115
Nome #
Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors, file e309ade1-8e2a-3969-e053-3a05fe0a2c94 360
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients, file e309ade2-01e2-3969-e053-3a05fe0a2c94 277
Development of sentinel node localization and ROLL in breast cancer in Europe, file e309ade1-7592-3969-e053-3a05fe0a2c94 191
Improper use of "radioguided occult lesion localization" (ROLL) technique leads to misleading conclusions, file e309ade1-89a3-3969-e053-3a05fe0a2c94 189
Early use of abiraterone and radium-223 in metastatic prostate cancer, file e309ade2-3c33-3969-e053-3a05fe0a2c94 176
Dosimetry of 177Lu-PSMA-617 after mannitol infusion and glutamate tablet administration: Preliminary results of EUDRACT/RSO 2016-002732-32 IRST protocol, file e309ade2-1d64-3969-e053-3a05fe0a2c94 171
A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions, file e309ade2-3b02-3969-e053-3a05fe0a2c94 138
Interim analysis of the REASSURE (Radium-223 alpha Emitter Agent in non-intervention Safety Study in mCRPC popUlation for long-teRm Evaluation) study: patient characteristics and safety according to prior use of chemotherapy in routine clinical practice, file e309ade2-3b85-3969-e053-3a05fe0a2c94 127
Eleven-year experience with the avidin-biotin pretargeting system in glioblastoma: Toxicity, efficacy and survival, file e309ade1-8546-3969-e053-3a05fe0a2c94 124
Positron emission tomography in the diagnostic work-up of screening-detected lung nodules, file e309ade1-82b8-3969-e053-3a05fe0a2c94 118
Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours, file e309ade1-8490-3969-e053-3a05fe0a2c94 101
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis, file e309ade1-c505-3969-e053-3a05fe0a2c94 101
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE, file e309ade1-7a71-3969-e053-3a05fe0a2c94 99
Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging, file e309ade1-7c57-3969-e053-3a05fe0a2c94 89
Yttrium-labelled peptides for therapy of NET, file e309ade1-85e4-3969-e053-3a05fe0a2c94 86
Investigation of 90Y-avidin for prostate cancer brachytherapy: A dosimetric model for a phase I-II clinical study, file e309ade1-8d53-3969-e053-3a05fe0a2c94 65
A novel radioguided surgery technique exploiting β- decays, file e309ade1-8e28-3969-e053-3a05fe0a2c94 60
Texture analysis in 177Lu SPECT phantom images: Statistical assessment of uniformity requirements using texture features, file e309ade3-aff6-3969-e053-3a05fe0a2c94 60
Intramedullary spinal cord metastases from breast cancer: Detection with 18F-FDG PET/CT, file e309ade1-8a44-3969-e053-3a05fe0a2c94 58
Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: Efficacy profile, safety, and quality of life, file e309ade1-7803-3969-e053-3a05fe0a2c94 56
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images, file e309ade2-3151-3969-e053-3a05fe0a2c94 53
Atypical primary pulmonary meningioma: A report of a case suspected of being a lung metastasis, file e309ade1-7c59-3969-e053-3a05fe0a2c94 49
Secondary acute myeloid leukaemia after peptide receptor radionuclide therapy, file e309ade1-8d0a-3969-e053-3a05fe0a2c94 48
CAR-T cell therapy: A potential new strategy against prostate cancer, file e309ade2-e3be-3969-e053-3a05fe0a2c94 46
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART®) combined with external beam radiation therapy, file e309ade1-83d7-3969-e053-3a05fe0a2c94 43
Quantitative accuracy of177Lu SPECT imaging for molecular radiotherapy, file e309ade1-ae1a-3969-e053-3a05fe0a2c94 41
Spotlight on PSMA as a new theranostic biomarker for bladder cancer, file e309ade4-e638-3969-e053-3a05fe0a2c94 40
PET/CT and breast cancer subtypes, file e309ade1-909f-3969-e053-3a05fe0a2c94 39
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting, file e309ade5-42a1-3969-e053-3a05fe0a2c94 39
Preoperative PET/CT in earlystage breast cancer: Is the TNM classification enough?, file e309ade1-8a46-3969-e053-3a05fe0a2c94 37
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?, file e309ade1-8cdf-3969-e053-3a05fe0a2c94 36
Prostate-specific membrane antigen and renal cell carcinoma: A new diagnostic and therapeutic target?, file e309ade2-b504-3969-e053-3a05fe0a2c94 36
Dosimetric issues associated with percutaneous ablation of small liver lesions with 90Y, file e309ade2-e564-3969-e053-3a05fe0a2c94 12
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome, file e309ade4-e416-3969-e053-3a05fe0a2c94 11
A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm, file e309ade2-e5c6-3969-e053-3a05fe0a2c94 10
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials, file a75a43a0-f18f-4ec5-891b-97bf4a609a1c 9
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study, file e309ade2-e5cf-3969-e053-3a05fe0a2c94 9
68ga-psma-11 pet/ct-guided stereotactic body radiation therapy retreatment in prostate cancer patients with psa failure after salvage radiotherapy, file e309ade4-e04a-3969-e053-3a05fe0a2c94 9
[18 f]f-psma-1007 radiolabelling without an on-site cyclotron: A quality issue, file e309ade4-e5bc-3969-e053-3a05fe0a2c94 8
PET/CT in Multiple Myeloma: Beyond FDG, file e309ade4-f2d1-3969-e053-3a05fe0a2c94 8
Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of 225Ac-PSMA (Prostate-Specific Membrane Antigen), file e309ade2-e562-3969-e053-3a05fe0a2c94 7
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging, file e309ade4-e411-3969-e053-3a05fe0a2c94 7
177 lu-psma radioligand therapy is favorable as third-line treatment of patients with metastatic castration-resistant prostate cancer. A systematic review and network meta-analysis of randomized controlled trials, file e309ade4-e9fb-3969-e053-3a05fe0a2c94 7
Optimizing psma radioligand therapy for patients with metastatic castration-resistant prostate cancer. A systematic review and meta-analysis, file e309ade5-3bcd-3969-e053-3a05fe0a2c94 7
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 study, file e309ade2-e55a-3969-e053-3a05fe0a2c94 6
Exploratory Analysis of 18F-3’-deoxy-3’-fluorothymidine (18F-FLT) PET/CT-Based Radiomics for the Early Evaluation of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer, file e309ade4-e5ba-3969-e053-3a05fe0a2c94 6
Importance of pet with 68ga-labeled somatostatin analogs, file e309ade4-e04c-3969-e053-3a05fe0a2c94 5
Targeted radioactive therapy for prostate cancer, file e309ade4-e636-3969-e053-3a05fe0a2c94 5
Radiology imaging management in an Italian cancer center (IRST IRCCS) during the COVID-19 pandemic, file e309ade5-07ca-3969-e053-3a05fe0a2c94 5
Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy, file e309ade5-4096-3969-e053-3a05fe0a2c94 5
Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET, file e309ade1-829f-3969-e053-3a05fe0a2c94 4
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest, file 085b77f4-afb5-48e9-9395-4233c4e71420 3
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors, file 35a623f5-dfcb-4716-8085-db13a7b9a994 3
Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC, file e309ade1-7612-3969-e053-3a05fe0a2c94 3
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE, file e309ade1-78e1-3969-e053-3a05fe0a2c94 3
Yttrium-based therapy for neuroendocrine tumors, file e309ade1-79a7-3969-e053-3a05fe0a2c94 3
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide, file e309ade1-826a-3969-e053-3a05fe0a2c94 3
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients, file e309ade3-58c5-3969-e053-3a05fe0a2c94 3
Are we ready for an early evaluation of the response of axillary lymph node metastases to neoadjuvant therapy?, file e309ade1-88cb-3969-e053-3a05fe0a2c94 2
OXavidin for tissue targeting biotinylated therapeutics, file e309ade1-8b32-3969-e053-3a05fe0a2c94 2
A parathyroid carcinoma within a cold thyroid nodule, file e309ade1-8b35-3969-e053-3a05fe0a2c94 2
Kidney dosimetry in 177Lu and 90Y peptide receptor radionuclide therapy: Influence of image timing, time-activity integration method, and risk factors, file e309ade1-8b4d-3969-e053-3a05fe0a2c94 2
Muscle metastases from gallbladder cancer, file e309ade1-8d12-3969-e053-3a05fe0a2c94 2
Detection of a cardiac mass by [18F]FDG-PET/CT: A rare case, file e309ade1-a5bc-3969-e053-3a05fe0a2c94 2
Development of sentinel node biopsy, ROLL and IART in early breast cancer at the European Institute of Oncology, Milan (IEO), file e309ade1-b694-3969-e053-3a05fe0a2c94 2
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer, file e309ade1-b8ee-3969-e053-3a05fe0a2c94 2
Reduction of68Ga-PSMA renal uptake with mannitol infusion: preliminary results, file e309ade1-c4f7-3969-e053-3a05fe0a2c94 2
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors, file e309ade2-bead-3969-e053-3a05fe0a2c94 2
SUV95th as a Reliable Alternative to SUVmax for Determining Renal Uptake in [68Ga] PSMA PET/CT, file e309ade2-e5c5-3969-e053-3a05fe0a2c94 2
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting, file e309ade4-f56d-3969-e053-3a05fe0a2c94 2
Adoptive immunotherapy by avidin-driven cytotoxic T lymphocyte-tumor bridging, file 1614eb81-00b8-4483-8af0-6a275e7358f1 1
Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status, file e309ade1-7958-3969-e053-3a05fe0a2c94 1
Peptide Receptor Radionuclide Therapy (PRRT): clinical Application, file e309ade1-795b-3969-e053-3a05fe0a2c94 1
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors, file e309ade1-7972-3969-e053-3a05fe0a2c94 1
Design and solid phase synthesis of new DOTA conjugated (+)-biotin dimers planned to develop molecular weight-tuned avidin oligomers, file e309ade1-7b86-3969-e053-3a05fe0a2c94 1
Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretation, file e309ade1-7c2e-3969-e053-3a05fe0a2c94 1
Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors, file e309ade1-82a4-3969-e053-3a05fe0a2c94 1
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5], file e309ade1-82dc-3969-e053-3a05fe0a2c94 1
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies, file e309ade1-85e7-3969-e053-3a05fe0a2c94 1
Intraoperative beta- detecting probe for radio-guided surgery of brain tumors, file e309ade1-878e-3969-e053-3a05fe0a2c94 1
Treatment with the radiolabelled somatostatin analog Lu-DOTATATE for advanced pancreatic neuroendocrine tumors, file e309ade1-88b7-3969-e053-3a05fe0a2c94 1
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT images, file e309ade1-8a48-3969-e053-3a05fe0a2c94 1
Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases, file e309ade1-8a7b-3969-e053-3a05fe0a2c94 1
Hibernoma mimicking metastasis on positron emission tomography-computed tomography imaging: A misleading finding in oncologic patient follow-up, file e309ade1-8aab-3969-e053-3a05fe0a2c94 1
Roles of computed tomography and [ 18F]fluorodeoxyglucose- positron emission tomography/computed tomography in the characterization of multiple solitary solid lung nodules, file e309ade1-8d0d-3969-e053-3a05fe0a2c94 1
PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest, file e309ade2-e3b7-3969-e053-3a05fe0a2c94 1
Re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. Eur Urol. 2020;77: 508–47 https://doi.org/10.1016/j.eururo.2020.01.012, file e309ade2-e3b9-3969-e053-3a05fe0a2c94 1
Clinical value of negative 68Ga-PSMA PET/CT in the management of biochemical recurrent prostate cancer patients, file e309ade2-e3bb-3969-e053-3a05fe0a2c94 1
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients, file e309ade2-e55c-3969-e053-3a05fe0a2c94 1
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review, file e309ade2-e5cd-3969-e053-3a05fe0a2c94 1
Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index, file e309ade3-50a7-3969-e053-3a05fe0a2c94 1
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors, file e309ade4-cfbb-3969-e053-3a05fe0a2c94 1
Totale 3.360
Categoria #
all - tutte 10.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1
Totale 10.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201993 0 0 0 0 0 0 0 0 0 0 43 50
2019/2020395 47 34 20 45 43 29 35 35 40 17 28 22
2020/2021472 14 20 17 14 37 26 36 50 44 58 60 96
2021/2022889 35 38 45 103 84 34 67 56 63 44 213 107
2022/2023942 23 94 200 126 44 90 86 86 46 39 76 32
2023/2024565 54 58 82 37 66 92 40 74 62 0 0 0
Totale 3.360